Skip to main content

Table 3 Referral to Hospice Palliative Care before (Group 1) and after (Group 2) the implementation of the Life-Sustaining Treatment Decisions Act

From: Changes in decision-making process for life-sustaining treatment in patients with advanced cancer after the life-sustaining treatment decisions-making act

Variables Group 1
(n = 943)
Group 2
(n = 891)
p-value
HPC referral 398 (42.2 %) 607 (68.1 %) < 0.001
Consent to HPCa 334 (83.9 %) 487 (80.2 %) < 0.001
HPC referral to death, day (Mean ± SD)a 36.5 ± 52.9 46.0 ± 79.5 0.035
  1. aanalyzed from cases referred to HPC (n = 1005; 398 from group 1, 607 from group 2)
  2. HPC hospice palliative care; SD standard deviation